Results 91 to 100 of about 24,553 (208)

Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives [PDF]

, 2022
Hamideh Raeisi, Masoumeh Azimirad, Hamid Asadzadeh Aghdaei, Abbas Yadegar, Mohammad Reza Zali   +4 more
openalex   +1 more source

Molecular epidemiology of Clostridioides difficile in patients with inflammatory bowel disease in China [PDF]

, 2019
Tao� Lv, Yunbo Chen, Lisi Zheng, Tao Wu, Ping Shen, Lanjuan Li   +5 more
openalex   +1 more source

Risk of Acute Kidney Injury andClostridioides difficileInfection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin [PDF]

, 2020
Jazmin D Lee, Brett H. Heintz, Hilary J. Mosher, Daniel J. Livorsi, Jason A. Egge, Brian C. Lund   +5 more
openalex   +1 more source

Dominance of toxigenic Clostridioides difficile strains and the appearance of the emerging PCR ribotype 955 in hospitals in Silesia, Poland

Frontiers in Microbiology
IntroductionToxigenic strains of Clostridioides difficile are the leading cause of healthcare-associated bacterial infections in Poland. In the Silesian Voivodeship, with 4.5 million inhabitants, the incidence of C.
Klaudia Szarek, Natalia Frankowska, Natalia Frankowska, Monika Kabała, Wiep Klaas Smits, Dorota Wultańska, Piotr Lalowski, Hanna Pituch, Adam Iwanicki, Krzysztof Hinc, Céline Harmanus, Ingrid M. J. G. Sanders, Robert Wojtyczka, Tomasz J. Wąsik   +13 more
doaj   +1 more source

Economic burden attributable to Clostridioides difficile infections in South Korea: a nationwide propensity score-matched study

, 2021
Kang Ju Son, Y.A. Kim, Y.S. Park
openalex   +2 more sources

Wolf in Sheep’s Clothing: Clostridioides difficile Biofilm as a Reservoir for Recurrent Infections [PDF]

, 2021
Jazmín Meza‐Torres, Emile Auria, Bruno Dupuy, Yannick D. N. Tremblay   +3 more
openalex   +1 more source

A Review of Therapies for Clostridioides difficile Infection

Antibiotics
Clostridioides difficile is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of Clostridioides difficile infection (CDI), it remains a ...
Faiza Morado, Neha Nanda
doaj   +1 more source

Characterisation and antibiotic susceptibility profile of Clostridioides (Clostridium) difficile isolated from chicken carcasses [PDF]

, 2020
Enver Barış Bingöl, Hamparsun Hampikyan, Karlo Muratoğlu, Esra Akkaya, Ömer Çetin, Hilal Çolak   +5 more
openalex   +1 more source

In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection [PDF]

, 2021
Nader S. Abutaleb, Mohamed N. Seleem
openalex   +1 more source

Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort

BMC Infectious Diseases
Background Recurrent Clostridioides difficile infection is most effectively treated with faecal microbiota transplantation. Swedish and European guidelines suggest faecal microbiota transplantation after a first or second recurrence, respectively.
Måns Stefansson, Oscar Bladh, Piotr Nowak, Lars Rombo, Magnus Hedenstierna, Johan Ursing   +5 more
doaj   +1 more source